From Psoriasis To Arthritis
Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence Psoriatic arthritis (PsA), a chronic inflammatory arthritis, affects about 10 % of patients…
The 9 Muses are daughters of Zeus and Mnemosyne, Greek goddesses personifying the inspiration for the sciences and the arts.
My highly opinionated news-blog draws inspiration from both the science and the art of Rheumatology.
The Psoriatic Plague
Fewer Psoriasis Patients Satisfied with Current Treatments Science Daily reports the results of a new survey by Health Union that assessed nearly 600 individuals with plaques psoriasis. They found that…
PsO/PsA & Th22/Th9
Th22 Cells Contribution in Immunopathogenesis of Rheumatic Diseases Newly identified T helper cell 22 (Th22) is a subset of CD4+T cells with specific properties apart from other known CD4+ T…
T-helper 22 (Th22)
Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodelling 1Molecular Immunology, Department of Allergy and Clinical Immunology, National Heart and Lung… jci.org Th22 cells…
T-helper 9 (Th9)
IL-9 and Th9 cells: progress and challenges T[h] 9 cells are a new subset of helper T cells, and the signature cytokine for T[h] 9 cells is IL-9. Both T[h]…
Autoimmune Heterogeneity
Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies Recent advances in genetics have deepened our understanding of the pathogenic mechanisms behind autoimmune and immune-mediated diseases.…
Ustekinumab & Th17
IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases Cua and colleagues discuss the cellular and molecular rationale for targeting IL-12 and IL-23 for therapeutic purposes…
MAIT Cells & Th17
MAIT cells: not just another brick in the wall The link between gut and joint inflammation in spondyloarthritis (SpA) is well established, in particular in ankylosing spondylitis (AS) and peripheral…
Secukinumab & Th17
Secukinumab for rheumatology: development and its potential place in therapy Secukinumab for rheumatology: development and its potential place in therapy Marije I Koenders, Wim B… dovepress.com|By Dove Press Study Finds…
Adalimumab
Long-Term Safety of Adalimumab Reviewed Burmester and colleagues have published their review of the long-term outcomes and safety issues with the TNF inhibitor, adalimumab (ADA). The analysis included… rheumnow.com Adalimumab Approved…
- Go to the previous page
- 1
- …
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- …
- 108
- Go to the next page